MORE►
AbbVie
Panelists at the BioNTX summit family office discussion included, from left, Timothy Morris of Aacolade Pharma, Vic Stone of Alloy Therapeutics, Justin Yang of GHIC, and Yizhen Dong of Echo Investment Capital. The discussion was moderated by Weaver’s Tyler Ridley. [Photo: BioNTX]
Keys to Tapping Family Office Money: Pinpoint Their Passion, and ‘One Meeting in Person Equals 1,000 Emails’
by Glenn Hunter | Oct 24, 2024
Fundraising has slowed and valuations are down, but biotech founders could have a lifeline in family office investments, panelists at the recent BioNTX summit in Arlington agreed. They said succeeding with these investors can take time, a lot of education, and a compelling, well-crafted story that connects emotionally with the family.
by Lance Murray |
Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
MORE►
by Quincy Preston |
Jun 14, 2024
The North Texas chapter of the National Association of Corporate Directors has appointed Renee Arrington as board chair. Former Dallas Mayor Tom Leppert will serve as vice chair. The platform for corporate directorship, which helps members stay ahead of critical issues such as cyber risk and CEO succession planning, focuses on governance challenges and sharing knowledge.
MORE►
